Reaction
Skin Wrinkling reporting signals
As of the last recalculation, Skin Wrinkling appears in 2,677 FAERS reports alongside 35 co-occurring drug terms. The strongest observed disproportionality signal is ONABOTULINUMTOXINA (PRR 37.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Onabotulinumtoxina | 329 | 37.6 | 37.8 |
| Tretinoin | 23 | 22.2 | 22.3 |
| Mometasone | 44 | 18.9 | 19.0 |
| Botulinum Toxin Type A | 22 | 13.9 | 13.9 |
| Doxepin | 14 | 10.8 | 10.8 |
| Sulfur | 10 | 9.3 | 9.3 |
| Doxepin Hydrochloride | 14 | 8.7 | 8.7 |
| Asfotase Alfa | 11 | 8.6 | 8.6 |
| Erythromycin | 19 | 7.9 | 7.9 |
| Minoxidil Foam 5% (Womens) | 31 | 7.4 | 7.4 |
| Mometasone Furoate | 38 | 7.2 | 7.2 |
| Minoxidil | 40 | 7.0 | 7.0 |
| Biotin | 27 | 6.8 | 6.8 |
| Diltiazem Hydrochloride Extended-Release Tablets | 9 | 6.2 | 6.2 |
| Adapalene | 132 | 5.9 | 5.9 |
| Hydroxyzine Hydrochloride | 9 | 5.3 | 5.3 |
| Hydroxyzine Hydrochloride Oral | 9 | 5.3 | 5.3 |
| Anastrozole | 24 | 5.1 | 5.1 |
| Panitumumab | 10 | 5.0 | 5.0 |
| Ribociclib | 19 | 4.7 | 4.7 |
| Bimatoprost | 17 | 4.6 | 4.6 |
| Gefitinib | 5 | 4.3 | 4.3 |
| Crisaborole | 5 | 4.1 | 4.1 |
| Lapatinib | 7 | 3.5 | 3.5 |
| Salicylic Acid | 22 | 3.3 | 3.3 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 4 | 3.1 | 3.1 |
| Oral Semaglutide | 28 | 3.0 | 3.0 |
| Relugolix | 9 | 3.0 | 3.0 |
| Teriparatide | 39 | 2.7 | 2.7 |
| Isotretinoin | 16 | 2.5 | 2.5 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 7 | 2.3 | 2.3 |
| Cabozantinib | 14 | 2.3 | 2.3 |
| Trifluridine And Tipiracil | 3 | 2.2 | 2.2 |
| Dupilumab | 105 | 1.7 | 1.7 |
| Tirzepatide | 23 | 1.1 | 1.1 |